| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $335,223 | +1,020 | +24% | $328.65 | 5,289 | 04 Feb 2025 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $286,295 | +1,103 | +21% | $259.56 | 6,392 | 04 Feb 2025 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Disposed to Issuer | $404,775 | -695 | -11% | $582.41 | 5,697 | 04 Feb 2025 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Disposed to Issuer | $373,325 | -641 | -11% | $582.41 | 5,056 | 04 Feb 2025 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | $416,552 | -715 | -14% | $582.59 | 4,341 | 04 Feb 2025 | Direct | F1 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | $166,457 | -285 | -6.6% | $584.06 | 4,056 | 04 Feb 2025 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | $458,003 | -787 | -19% | $581.96 | 3,269 | 04 Feb 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -1,020 | -100% | $0.000000 | 0 | 04 Feb 2025 | Common Stock, Par Value $0.01 Per Share | 1,020 | $328.65 | Direct | F2 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -1,103 | -50% | $0.000000 | 1,104 | 04 Feb 2025 | Common Stock, Par Value $0.01 Per Share | 1,103 | $259.56 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Reflects a weighted average sale price of $582.59 at prices ranging from $582.410 to $583.130 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F2 | One third of the Stock Appreciation Rights became exercisable on 12/10/2022 and each year thereafter. The entire grant became fully exercisable on 12/10/2024. |
| F3 | One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025. |